7-5501156-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_024963.6(FBXL18):āc.1113C>Gā(p.Asp371Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,460,812 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_024963.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXL18 | NM_024963.6 | c.1113C>G | p.Asp371Glu | missense_variant | 3/5 | ENST00000382368.8 | NP_079239.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXL18 | ENST00000382368.8 | c.1113C>G | p.Asp371Glu | missense_variant | 3/5 | 5 | NM_024963.6 | ENSP00000371805.3 | ||
FBXL18 | ENST00000458142.1 | c.762C>G | p.Asp254Glu | missense_variant | 1/3 | 2 | ENSP00000405896.1 | |||
FBXL18 | ENST00000415009.5 | n.1113C>G | non_coding_transcript_exon_variant | 3/7 | 2 | ENSP00000415064.1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460812Hom.: 0 Cov.: 78 AF XY: 0.00000138 AC XY: 1AN XY: 726736
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.1113C>G (p.D371E) alteration is located in exon 3 (coding exon 3) of the FBXL18 gene. This alteration results from a C to G substitution at nucleotide position 1113, causing the aspartic acid (D) at amino acid position 371 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at